Health Care Archives - Page 17 of 478

2 minute read

This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan

May 21, 10:41 PM

The Structure Therapeutics stock has been identified as a potential winner in the obesity drug market. JPMorgan has given the stock a significant upside potential.

BHVN

2 minute read

EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic

By Piero Cingari

May 21, 4:33 PM

Roundhill CEO Dave Mazza says investors "can't just buy a basket of big pharma names or a broad-based biotech ETF and call it a day."

AMGN

1 minute read

Orthopedic Implants Maker Zimmer Biomet Gains Analyst Upgrade Amid Promising Growth From New Products, Demographic Trends

By Vandana Singh

May 21, 2:42 PM

Zimmer Biomet receives an upgrade from Argus Research due to new product launches and strategic acquisitions.

ZBH

2 minute read

Larimar Therapeutics’ Friedreich’s Ataxia Investigational Drug Differentiated From Biogen’s Marketed Drug

By Vandana Singh

May 21, 2:39 PM

Larimar Therapeutics announces FDA lift of partial clinical hold on nomlabofusp (CTI-1601) for Friedreich's Ataxia. Data from Phase 2 study shows well-tolerated treatment with significant frataxin level increases.

BIIB

2 minute read

What’s Going On With Colorectal Cancer Diagnostic-Focused Guardant Health Stock On Tuesday?

By Vandana Singh

May 21, 2:36 PM

FDA staff reviewers raise concerns over Guardant Health's experimental Shield blood test for colorectal cancer, citing low sensitivity in detecting certain tumor types. Shield aims to improve early CRC detection and compliance, potentially extending patient survival.

2 minute read

Weight Loss Drugs Like Wegvoy and Zepbound Users – Nestlé Launches $5 Pizza For You

By Vandana Singh

May 21, 2:25 PM

Nestlé SA launches Vital Pursuit, a new food line tailored for GLP-1 weight loss medication users, featuring protein, fiber, and essential nutrients. Available Q4 nationwide.

LLY

2 minute read

Citius Pharma’s ‘Antibiotic Lock’ Effective In Patients With Catheter-Associated Bloodstream Infections

By Vandana Singh

May 21, 1:40 PM

Citius Pharmaceuticals' Phase 3 trial results for Mino-Lok, an antibiotic lock solution for central line-associated infections, show significant improvement in time to catheter failure and overall treatment success.

CTXR

2 minute read

GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims

By Vandana Singh

May 21, 12:48 PM

Valisure sues GSK accusing the company of hiding cancer risks linked to Zantac, potentially defrauding the U.S. government. This follows Valisure's 2019 tests showing Zantac forms a carcinogen, prompting a whistleblower lawsuit seeking billions in damages.

GSK

1 minute read

UnitedHealth’s OptumRx Unveils New Transparent Drug Pricing Initiative for 2024

By Vandana Singh

May 21, 10:54 AM

UnitedHealth's OptumRx will implement a new pricing model, OptumRx Clear Trend Guarantee, starting next year.

CAH

2 minute read

Eli Lilly Secures China Nod For Popular Weight Loss/Diabetes Drug Tirzepatide

By Vandana Singh

May 21, 9:36 AM

Eli Lilly's diabetes drug tirzepatide receives approval in China, intensifying competition with Novo Nordisk's Ozempic. This move signals a significant expansion in the Asian market, where GLP-1 agonists are poised to drive a $2 billion market by 2030.

LLY